Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer

BACKGROUND: Following the functional and physicochemical characterization of a proposed biosimilar, comparative clinical studies help to confirm biosimilarity by demonstrating similar safety and efficacy to the reference product in a sensitive patient population. PATIENTS AND METHODS: LA-EP2006 is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackwell, K., Gascon, P., Jones, C. M., Nixon, A., Krendyukov, A., Nakov, R., Li, Y., Harbeck, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834021/
https://www.ncbi.nlm.nih.gov/pubmed/28637287
http://dx.doi.org/10.1093/annonc/mdx303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834021/
https://www.ncbi.nlm.nih.gov/pubmed/28637287
http://dx.doi.org/10.1093/annonc/mdx303

Ejemplares similares